BD-1008 is a nonselective sigma receptor antagonist with Kis against sigma1 receptor and sigma2 receptor of 2 nM and 8 nM. The BD-1008 has an extremely low affinity for the D2 receptor (Ki = 1112 nM) and dopamine transporter (DAT) (Ki > 10,000 nM). BD-1008 significantly antagonizes dopamine release in the shell region of the nucleus accumbens via the sigma2 receptor. BD-1008 blocks the self-administration behavior of sigma agonists.BD-1008 can be used for the study of addiction therapy that target the sigma receptor[1][2][3].
Molecular Weight:
301.25
Purity:
98.41
CAS Number:
[138356-08-8]
Formula:
C15H22Cl2N2
Target:
Sigma Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
